tiragolumab
roche
['tiragolumab']
#asco22 here, full analysis set includes those with brain metastases. no benefit seen with addition of tiragolumab but overall, outcomes comparable to primary analysis set, confirming inclusion of pts with untreated brain metastases appropriate. 
Director of Thoracic Oncology & Developmental Therapeutics @LombardiCancer, Associate Professor @Georgetown University #LCSM #HereWeGo #ITYSL He/Him